Bradykinin analogs containing the 4-amino-2-benzazepin-3-one scaffold at the C-terminus
✍ Scribed by S. Ballet; R. De Wachter; K. Van Rompaey; Cs. Tömböly; D. Feytens; G. Töth; L. Quartara; P. Cucchi; S. Meini; D. Tourwé
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 243 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1075-2617
- DOI
- 10.1002/psc.827
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
High affinity peptide ligands for the bradykinin (BK) B~2~ subtype receptor have been shown to adopt a β‐turn conformation of the C‐terminal tetrapeptide (H‐Arg^1^‐Pro^2^‐Pro^3^‐Gly^4^‐Phe^5^‐Ser^6^‐Pro^7^‐Phe^8^‐Arg^9^‐OH). We investigated the replacement of the Pro^7^‐Phe^8^ dipeptide moiety in BK or the D‐Tic^7^‐Oic^8^ subunit in HOE140 (H‐D‐Arg^0^‐Arg^1^‐Pro^2^‐Hyp^3^‐Gly^4^‐Thi^5^‐Ser^6^‐D‐Tic^7^‐Oic^8^‐Arg^9^‐OH) by 4‐amino‐1,2,4,5‐tetrahydro‐2‐benzazepin‐3‐one templates (Aba). Binding studies to the human B~2~ receptor showed a correlation between the affinities of the BK analogs and the propensity of the templates to adopt a β‐turn conformation. The L‐spiro‐Aba‐Gly containing HOE140 analog BK10 has the best affinity, which correlates with the known turn‐inducing property of this template. All the compounds did not modify basal inositolphosphate (IP) output in B~2~‐expressing CHO cells up to 10 µM concentration. The antagonist properties were confirmed by the guinea pig ileum smooth muscle contractility assay. The new amino‐benzazepinone (Aba) substituted BK analogs were found to be surmountable antagonists. Copyright © 2007 European Peptide Society and John Wiley & Sons, Ltd.